central-nervous-system-2016_posters-accepted-abstracts

28 / 42

Notes:
Page 84
CNS 2016
December 05-07, 2016
Volume 7, Issue 5(Suppl) J Neurol Neurophysiol
ISSN: 2155-9562 JNN, an open access journal
conferenceseries .com
December 05-07, 2016 Dubai, UAE
2nd International Conference on
Central Nervous System Disorders & Therapeutics
Hussein Algahtani et al., J Neurol Neurophysiol 2016, 7:5(Suppl)
Posterior reversible encephalopathy syndrome: Local experience from Saudi Arabia
Hussein Algahtani, Abdulhadi Algahtani, Ahmad Aldarmahi, Mohammed Hmoud, Yousef Marzuk and Bader Shirah
King Saud bin Abdulaziz University for Health Sciences, KSA
Objectives:Posterior reversible encephalopathy syndrome (PRES) is a clinicoradiological syndrome characterized by headache,
altered mental status, seizures, or loss of vision. In this study, we report the largest series of PRES coming from Saudi Arabia and
explore the etiology, clinical presentation, and outcome. We also report new imaging findings associated with this condition.
Methods: We performed a retrospective study of all cases of PRES admitted to King Abdulaziz Medical City, Jeddah, Saudi
Arabia, between the years 2005 and 2015. A neurologist reviewed all charts and analyzed the clinical presentations, etiological
factors, and outcomes, and a neuroradiologist reviewed the imaging studies. Only patients with clinical and imaging features
consistent with PRES were included in the study.
Results: We collected 31 patients who had clinical and radiological features consistent with PRES. Females were more affected
than males (18 females and 13 males), and patients’ age ranged from 6 to 95 years, with a mean of 38.3 years. Patients were
treated by removing the precipitating causes and treating the underlying conditions. Resolution of neurologic signs occurred
within 2 to 3 weeks in all patients.
Conclusion: In our opinion, PRES itself is usually a benign condition with complete recovery if the condition is recognized
early and managed appropriately. Although clinical signs are nonspecific, the constellation of symptoms including headache,
visual problems, seizures, and altered level of consciousness should suggest the possibility of PRES, especially in high-risk
group. Abnormalities on magnetic resonance imaging are often characteristic and may be the first clue to the diagnosis.
Biography
Hussein Algahtani is the Associate Dean of Clinical Affairs and the Head of the simulation Center in the College of Medicine at King Saud bin Abdulaziz University
for Health Sciences in Jeddah, Saudi Arabia. He is also an Assistant Professor in Neurology and the neurosciences block coordinator. In addition, he is the
Neurology section Head and the Head of Neurophysiology laboratory at King Abdulaziz medical city in Jeddah, Saudi Arabia. He is a well-known researcher with
more than 50 publications in the literature.